Giving Anaesthetists Control

Safer Injection for Regional Anaesthesia


SAFIRA®: SAFer Injection for Regional Anaesthesia

  • Creates a single operator procedure
  • Engineered safety solution to control injection pressure threshold
  • Reduces chances of nerve injury
  • Improves patient safety

Winner: "Patient Safety Innovation of the Year" at the HSJ Patient Safety Awards 2021

Full story here

Current Regional Anaesthesia process:

Regional anaesthesia procedures require two operators - an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure.

It has been reported that anaesthetic solutions are often injected at high pressure.

High pressure can cause damage to nerve fascicles, with serious nerve damage occurring in up to 1% of procedures and transient nerve damage in up to 8% of cases [1,2].

A revolutionary new technology for Regional Anaesthesia:

SAFIRA® - SAFer Injection for Regional Anaesthesia - allows a single operator, an anaesthetist or anesthesiologist, to conduct the whole regional block at safer pressures.

SAFIRA® has been developed in line with international quality standards. Medovate is ISO 13485:2016 certified.

Contact Distributors:

Medovate have appointed distributors for this exciting new technology.

VYGON is the appointed distributor for Europe and the UK. Mercury Medical is the appointed distributor in the United States of America. There are also active distributors covering Australia and New Zealand.

Find details of all appointed distributors here.

Distributors for other countries are in the process of being appointed.

Videos about SAFIRA®:

Scroll down to find videos about the new SAFIRA® technology for regional anaesthesia.

[References: 1. Borgeat A, Blumenthal S. Nerve injury and regional anaesthesia [Internet]. Vol. 17, Current Opinion in Anaesthesiology. 2004 [cited 2020 Mar 31]. p.417–21. Available from: 2. Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth [Internet]. 2010 [cited 2020 Mar 31];105(S1):97–107. Available from:]

Product Images

Introducing SAFIRA® The SAFIRA® system SAFIRA® foot pedal operator SAFIRA® palm operator SAFIRA­® being used with NYSORA simulator Anaesthetist uses SAFIRA® for an ankle block "It is small enough that you can actually place it anywhere around the patient". SAFIRA® won the HSJ 'Patient Safety Innovation of the Year' 2021

"During hands on demonstrations of SAFIRA® at events including WAMM 2019, delegates were able to appreciate the ease of use, the engineered safety benefits and the convenience of their ability to retain control as a single operator during the performance of a nerve block."

— Dr Peter Young, Critical Care Consultant, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

"Having full control over the injection means that I know exactly when, where and how much local anaesthetic I am putting into the patient. And also, the objective pressure limit which is built into the system, provides me with confidence that I am less likely to cause nerve injury."

— Dr Stewart Southey, Consultant Anaesthetist

"SAFIRA® can easily be integrated into clinical practice. The device is very familiar in terms of it being a modified syringe pump. In terms of usage for doing regional anaesthesia blocks, it is very intuitive and it is easy to understand how to aspirate and how to inject using the device."

— Dr Joseph Carter, Consultant Anaesthetist, York Teaching Hospitals NHS Foundation Trust

"My first impressions of SAFIRA® were the simplicity, the ease of use. New clinicians were able to just pick it up and use it straight away without any difficulty at all."

— Mr Chris Withey, Consultant Podiatric Surgeon

"SAFIRA® will not just make regional anaesthesia more convenient, it will also promote safer regional anaesthesia practice in operating rooms, in the wards and also in emergency departments. I believe SAFIRA® is the biggest development in regional anaesthesia since the introduction of ultrasound."

— Dr. Emad Eldin Fawzy, Consultant Anaesthetist, Shiekh Khalifa Medical City, Abu Dhabi, UAE

"The process of regional anaesthesia becomes essentially a solo procedure where I am in control of all aspects of my regional block. The uniformity with the lower pressures that I’m injecting all the time means the injection doesn’t vary like it might between different assistants. It just makes life so easy!"

— Dr Minh T. Tran, Senior Anaesthetist, Liverpool Hospital, Sydney, Australia

"I think from a volume point of view, from a nerve safety point of view and from a single handed complete control device, SAFIRA® helps you in all of those aspects and I can’t see any disadvantages to this device at present."

— Dr Morné Wolmarans, Consultant Anaesthetist, Norfolk and Norwich University Hospitals NHS Foundation Trust

"SAFIRA® gives complete control of the entire performance of peripheral nerve blocks to the anaesthetist. It allows slow and precise injection of local anaesthetic making the real time hydrodissection...very easy."

— Dr Peter Merjavy, Consultant Anaesthetist and Acute Pain Lead, Craigavon Area University Teaching Hospital, Northern Ireland, UK